Ulcerative Colitis

Treatment with Stelara for inflammatory bowel disease did not increase the risk for adverse maternal or fetal pregnancy outcomes, and infants exposed in utero reached developmental milestones in the first year of life, data showed.

In this Healio video exclusive, Michael V. Chiorean, MD, explains that physicians can safely and “with confidence” switch patients with inflammatory bowel disease from an originator biologic to a biosimilar at any point during treatment.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

LAS VEGAS — A presenter at the Crohn’s & Colitis Congress highlighted tips for successful decision-making with patients with inflammatory bowel disease, including how to approach conversations about the benefits and risks of treatments.

Use of a second anti-tumor necrosis factor agent resulted in early clinical response in nearly 50% of patients with ulcerative colitis and long-term remission in about 30%, with no difference reported between IV and subcutaneous agents.

In this Healio video, Aline Charabaty, MD clinical director of the Inflammatory Bowel Disease Center at Johns Hopkins, Sibley Memorial Hospital, discusses the underlying causes of ulcerative colitis.

In this Healio video, Aline Charabaty, MD clinical director of the Inflammatory Bowel Disease Center at Johns Hopkins, Sibley Memorial Hospital, discusses the underlying causes of ulcerative colitis.